COSCIENS Biopharma Inc. (CSCIF) vs Lunai Bioworks Inc. (LNAI)
COSCIENS Biopharma Inc. and Lunai Bioworks Inc. are both Biotechnology companies. COSCIENS Biopharma Inc. and Lunai Bioworks Inc. are of similar size ($8.8M and $8.6M). Lunai Bioworks Inc. has negative trailing earnings, so its P/E is not meaningful; COSCIENS Biopharma Inc. trades at 1.0×. COSCIENS Biopharma Inc. has the higher net margin (75.1% vs 0.00%) and the lower return on invested capital (−40.6% vs 0.00%). Across the 12 metrics below, COSCIENS Biopharma Inc. leads on 8 and Lunai Bioworks Inc. on 4.
Valuation
Profitability
| Metric | CSCIF | LNAI | Biotechnology median |
|---|---|---|---|
| Gross margin | 46.48% | 0.00% | 65.16% |
| Operating margin | (71.13%) | 0.00% | 0.00% |
| Net margin | 75.11% | 0.00% | 0.00% |
| Free cash flow margin | (40.36%) | 0.00% | 0.00% |
| Return on equity | 59.74% | (325.46%) | (57.72%) |
| Return on assets | 28.24% | (201.09%) | (49.22%) |
| Return on invested capital | (40.56%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack